Literature DB >> 19694760

Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.

S Nseir1, G Grailles, A Soury-Lavergne, F Minacori, I Alves, A Durocher.   

Abstract

The aim of this prospective observational study was to determine the accuracy of American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) criteria in predicting infection or colonization related to multidrug-resistant (MDR) bacteria at intensive-care unit (ICU) admission. MDR bacteria were defined as methicillin-resistant Staphylococcus aureus, ceftazidime-resistant or imipenem-resistant Pseudomonas aeruginosa, Acinetobacter baumannii, Stenotrophomonas maltophilia, and extended-spectrum β-lactamase-producing Gram-negative bacilli. Screening for MDR bacteria (using nasal and rectal swabs and tracheal aspirates from intubated patients) was performed at ICU admission. Risk factors for infection or colonization with MDR bacteria at ICU admission were determined using univariate and multivariate analyses. The accuracy of ATS/IDSA criteria in predicting infection or colonization with these bacteria at ICU admission was calculated. Eighty-three (13%) of 625 patients were infected or colonized with MDR bacteria at ICU admission. Multivariate analysis allowed identification of prior antimicrobial treatment (OR 2.3, 95% CI 1.2-4.3; p 0.008), residence in a nursing home (OR 2, 95% CI 1.1-3.7; p <0.001), and prior hospitalization (OR 3.9, 95% CI 1.7-8.8; p <0.001) as independent predictors of infection or colonization with MDR bacteria at ICU admission. Although sensitivity (89%) and negative predictive values (96%) were high, low specificity (39%) and a positive predictive value (18%) were found when ATS/IDSA criteria were used in predicting infection or colonization with MDR bacteria at ICU admission. In patients with pneumonia, adherence to guidelines was associated with increased rates of appropriate initial antibiotic treatment and de-escalation. ATS/IDSA criteria had an excellent negative predictive value and a low positive predictive value concerning infection or colonization with MDR bacteria at ICU admission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694760     DOI: 10.1111/j.1469-0691.2009.03027.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  22 in total

Review 1.  Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.

Authors:  Mical Paul; Vered Shani; Eli Muchtar; Galia Kariv; Eyal Robenshtok; Leonard Leibovici
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

Review 2.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

Authors:  Marin H Kollef; Yoav Golan; Scott T Micek; Andrew F Shorr; Marcos I Restrepo
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

4.  Emerging problems regarding severity assessment and treatment strategies for patients with pneumonia: controversies surrounding the HCAP concept.

Authors:  Yuichiro Shindo; Yoshinori Hasegawa
Journal:  Intern Emerg Med       Date:  2011-05-18       Impact factor: 3.397

5.  A propensity score analysis shows that empirical treatment with linezolid does not increase the thirty-day mortality rate in patients with Gram-negative bacteremia.

Authors:  Hugo-Guillermo Ternavasio-de la Vega; Ana-María Mateos-Díaz; Jose-Antonio Martinez; Manel Almela; Nazaret Cobos-Trigueros; Laura Morata; Cristina De-la-Calle; Marta Sala; Josep Mensa; Miguel Marcos; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2014-09-08       Impact factor: 5.191

6.  Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia.

Authors:  Karl J Madaras-Kelly; Richard E Remington; Vincent S Fan; Kevin L Sloan
Journal:  J Hosp Med       Date:  2011-10-28       Impact factor: 2.960

7.  Guideline-based antibiotics and mortality in healthcare-associated pneumonia.

Authors:  Karl J Madaras-Kelly; Richard E Remington; Kevin L Sloan; Vincent S Fan
Journal:  J Gen Intern Med       Date:  2012-03-07       Impact factor: 5.128

8.  Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.

Authors:  Hakjun Hyun; Joon Young Song; Jin Gu Yoon; Hye Seong; Ji Yun Noh; Hee Jin Cheong; Woo Joo Kim
Journal:  PLoS One       Date:  2022-06-29       Impact factor: 3.752

9.  The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit.

Authors:  Kostoula Arvaniti; Dimitrios Lathyris; Raymond Ruimy; Anna-Bettina Haidich; Vasiliki Koulourida; Pavlos Nikolaidis; Dimitrios Matamis; Spiros Miyakis
Journal:  Crit Care       Date:  2012-06-13       Impact factor: 9.097

Review 10.  Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program.

Authors:  José Garnacho Montero; Francisco Álvarez Lerma; Paula Ramírez Galleymore; Mercedes Palomar Martínez; Luis Álvarez Rocha; Fernando Barcenilla Gaite; Joaquín Álvarez Rodríguez; Mercedes Catalán González; Inmaculada Fernández Moreno; Jesús Rodríguez Baño; José Campos; Jesús Ma Aranaz Andrés; Yolanda Agra Varela; Carolina Rodríguez Gay; Miguel Sánchez García
Journal:  Crit Care       Date:  2015-03-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.